Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -3,137 | -6,855 | -3,982 | -947 | -1,562 |
| Depreciation Amortization | 229 | 644 | 406 | 255 | 107 |
| Accounts receivable | -3 | 18 | -39 | 14 | 48 |
| Accounts payable and accrued liabilities | 19 | -69 | -300 | -96 | -254 |
| Other Working Capital | 241 | 445 | 151 | -60 | -157 |
| Other Operating Activity | -537 | -3,283 | -2,749 | -2,745 | -129 |
| Operating Cash Flow | $-3,189 | $-9,099 | $-6,514 | $-3,580 | $-1,946 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 51 | N/A | N/A | N/A |
| PPE Investments | -97 | -673 | -710 | -471 | -378 |
| Net Acquisitions | N/A | N/A | 2,640 | 2,640 | N/A |
| Sale Of Investment | 80 | 2,915 | 490 | 412 | 274 |
| Purchase Sale Intangibles | -161 | -98 | -48 | N/A | N/A |
| Other Investing Activity | -161 | -23 | -48 | 0 | 0 |
| Investing Cash Flow | $-177 | $2,269 | $2,372 | $2,581 | $-105 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 4 | 20,744 | 20,707 | 1,757 | 264 |
| Financing Cash Flow | $4 | $20,744 | $20,707 | $1,757 | $264 |
| Beginning Cash Position | 22,467 | 8,553 | 8,553 | 8,553 | 8,553 |
| End Cash Position | 19,105 | 22,467 | 25,118 | 9,311 | 6,766 |
| Net Cash Flow | $-3,362 | $13,914 | $16,565 | $758 | $-1,787 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,189 | -9,099 | -6,514 | -3,580 | -1,946 |
| Capital Expenditure | -97 | -673 | -710 | -471 | -378 |
| Free Cash Flow | -3,285 | -9,772 | -7,223 | -4,051 | -2,324 |